Cyteir Therapeutics (CYTT) Stock Chart & Stock Price History → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free CYTT Stock Alerts $3.01 -0.01 (-0.33%) (As of 03/18/2024) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsSEC FilingsSocial MediaStock AnalysisChartEarningsFinancialsSEC FilingsSocial Media Cyteir Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance0.00% Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… CYTT Stock Chart for Monday, May, 20, 2024 CYTT Chart by TradingView Cyteir Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/16/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/15/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/14/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/13/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/10/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 millionMust-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story…05/09/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/08/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/07/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/06/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/03/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/02/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/01/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/30/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/29/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/26/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/25/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/24/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/23/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/22/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/19/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/18/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/17/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/16/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/15/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/12/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/11/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/10/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/09/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/08/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/05/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/04/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/03/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/02/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/01/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/29/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/28/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/27/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/26/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/25/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 millionMust-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story…03/22/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/21/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/20/2024N/A$3.01$3.19$2.92551,300 shs$108.36 million Related Companies: Allakos Stock Price Chart Citius Pharmaceuticals Stock Price Chart Cue Biopharma Stock Price Chart Assertio Stock Price Chart PMV Pharmaceuticals Stock Price Chart Genelux Stock Price Chart Relmada Therapeutics Stock Price Chart IO Biotech Stock Price Chart Rezolute Stock Price Chart OptiNose Stock Price Chart This page (NASDAQ:CYTT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward PressUrgent Nvidia WarningAltimetry"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA once-in-a-century investment opportunityStansberry Research Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
